Latest by HIV.gov
The 2017 Synchronicity Conference, a national conference that focuses on HIV and hepatitis C, also addressed LGBT health for the first time this year.
In response to user feedback, AIDSinfo is expanding its Drug Database to house more investigational drugs and will now also include investigational therapeutic HIV vaccines.
Nathan Fecik, M.P.H., shares highlights of federal activities to support scaling up this important HIV prevention tool.
A complement to the HIV care continuum, the new model is a better way of articulating what HIV prevention should look like today.
In an interview from Cape Town, South Africa, we hear from NIH's Carl Dieffenbach, Ph.D., about the exciting launch of HVTN 702, a new HIV vaccine clinical trial supported by NIH.
Learn about advances in HIV cure research from leaders in HIV science in two Facebook Live events from NIAID's Strategies for an HIV Cure conference.
Carl Dieffenbach, Ph.D., director of the Division of AIDS at NIH's National Institute of Allergy and Infectious Diseases (NIAID), discusses the important issue of viral suppression in this video.
NIH's Carl Dieffenbach, Ph.D., discusses new findings from the ASPIRE study about the experiences of women who used a vaginal ring at the recent HIV Research for Prevention Conference in Chicago.
Carl Dieffenbach, Ph.D., discusses what scientists now know about the benefits of HIV treatment and when people diagnosed with HIV should begin treatment at the the 2016 National Ryan White Conference on HIV Care and Treatment.
Shannon Hader, M.D., M.P.H., and Eugene McCray, M.D., reflect on what they've heard at the International AIDS Conference and shared some of the common approaches and priorities across U.S. and global HIV programs.